VARS2 V552V variant as prognostic marker in patients with early breast cancer

The present study analyzed the polymorphisms of DNA repair genes and their impact on the survival of 240 patients with early breast cancer. The genomic DNA was extracted from paraffin-embedded tumor-free tissue or blood, and thirteen polymorphisms in 12 DNA repair genes were determined using the Sequenom Mass array system. Among the target polymorphisms, VARS2 rs2074511 and POLE rs5744857 were found to correlate with survival after curative surgery in a log-rank test. No difference was found in the clinical and tumor characteristics according to the genotypes of these two coding variants, except for a higher incidence of positive ER in patients with the GG genotype of POLE rs5744857 (P = 0.025). Meanwhile, a multivariate analysis showed that the GG genotype of VARS2 V552 V (rs2301717) was significantly associated with disease-free survival (DFS; HR = 0.298; P = 0.044) and marginally with distant DFS (DDFS; HR = 0.266; P = 0.077). In particular, the VARS2 rs2074511 polymorphism was only associated with survival in patients with triple negative (TN)-type breast cancer (P = 0.018 for DFS and 0.042 for DDFS, respectively). In conclusion, VARS2 V552V may be considered as a prognostic factor for survival in patients with early breast cancer.

[1]  M. Horowitz,et al.  MHC class I, II, and III microsatellite marker matching and survival in unrelated donor hematopoietic cell transplantation. , 2007, Tissue antigens.

[2]  D. Kang,et al.  Genotype-phenotype relationship between DNA repair gene genetic polymorphisms and DNA repair capacity. , 2008, Asian Pacific journal of cancer prevention : APJCP.

[3]  L. Harris,et al.  First-Line Herceptin® Monotherapy in Metastatic Breast Cancer , 2001, Oncology.

[4]  W. Lafuse,et al.  The mouse p52 subunit of the transcription/DNA repair factor TFIIH is located in the class III region of the H2 complex: cloning and sequence polymorphism , 1999, Immunogenetics.

[5]  Paul Schimmel,et al.  Global effects of mistranslation from an editing defect in mammalian cells. , 2006, Chemistry & biology.

[6]  L. Oomen,et al.  A susceptibility gene for alveolar lung tumors in the mouse maps between Hsp70.3 and G7 within the H2 complex , 2004, Immunogenetics.

[7]  B. Ponder,et al.  Common Single-Nucleotide Polymorphisms in DNA Double-Strand Break Repair Genes and Breast Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.

[8]  W. Jin,et al.  Genetic Polymorphisms in the DNA Repair Enzyme ERCC2 and Breast Tumour Risk in a Chinese Population , 2008, The Journal of international medical research.

[9]  A. Hart,et al.  Effects of the MHC on hormonal induction of mammary tumors and function of hypophyseal isografts in the mouse , 2005, Immunogenetics.

[10]  J. Błasiak,et al.  Polymorphisms of the DNA Mismatch Repair Gene HMSH2 in Breast Cancer Occurence and Progression , 2005, Breast Cancer Research and Treatment.

[11]  X. Shu,et al.  A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  C. Ulrich,et al.  Polymorphisms in DNA repair genes and associations with cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  Robert W. Taylor,et al.  Overexpression of human mitochondrial valyl tRNA synthetase can partially restore levels of cognate mt-tRNAVal carrying the pathogenic C25U mutation , 2008, Nucleic acids research.

[14]  Chia-Hung Liu,et al.  FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization , 2006, Nucleic Acids Res..

[15]  M. Snoek,et al.  Genotype versus phenotype: conflicting results in mapping a lung tumor susceptibility locus to the G7c recombination interval in the mouse MHC class III region , 2001, Immunogenetics.

[16]  L. Cardon,et al.  Fine mapping of the MHC Class III region demonstrates association of AIF1 and rheumatoid arthritis. , 2008, Rheumatology.

[17]  C. Teuscher,et al.  Molecular analysis of the major MHC recombinational hot spot located within the G7c gene of the murine class III region that is involved in disease susceptibility. , 1998, Journal of immunology.

[18]  P. Schimmel,et al.  An editing-defective aminoacyl-tRNA synthetase is mutagenic in aging bacteria via the SOS response , 2007, Proceedings of the National Academy of Sciences.

[19]  S. Ackerman,et al.  Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration , 2006, Nature.

[20]  P. Hutter,et al.  Two common forms of the human MLH1gene may be associated with functional differences , 2000, Journal of medical genetics.

[21]  J. Jiricny,et al.  Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. , 2002, Gastroenterology.